Intravenous thrombolysis in young stroke patients results from the SITS-ISTR

Neurology

Volumn 78, Issue 12, 2012, Pages 880-887

  Toni, D ^a   Ahmed, N ^b   Anzini, A ^a   Lorenzano, S ^a   Brozman, M ^c   Kaste, M ^d   Mikulik, R ^e   Putaala, J ^d   Wahlgren, N ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c Hospital Nitra   (Slovakia)

^d HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^e ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; FIBRINOLYTIC AGENT; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BRAIN HEMORRHAGE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FIBRINOLYTIC THERAPY; GENDER; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; STROKE; SYSTOLIC BLOOD PRESSURE; ADOLESCENT; AGE; BLOOD PRESSURE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; EUROPEAN UNION; FACTUAL DATABASE; INDEPENDENT LIVING; INTRAVENOUS DRUG ADMINISTRATION; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; PHYSIOLOGY; PREDICTIVE VALUE; REGISTER; RISK; RISK FACTOR; SEX DIFFERENCE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BLOOD PRESSURE; CEREBRAL HEMORRHAGE; DATABASES, FACTUAL; EUROPEAN UNION; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INDEPENDENT LIVING; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PREDICTIVE VALUE OF TESTS; REGISTRIES; RISK FACTORS; SEX FACTORS; STROKE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84860327927     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e31824d966b     Document Type: Article

References (22)

1. Marini C, Totaro R, Carolei A. Long-term prognosis of cerebral ischemia in young adults. Stroke 1999;30:2320-2325. (Pubitemid 29517729)
2. Leys D, Bandu L, Henon H, et al. Clinical outcome in 287 consecutive young adults (15 to 45 years) with ischemic stroke. Neurology 2002;59:26-33. (Pubitemid 34742790)
3. Arnold M, Halpern M, Meier N, et al. Age-dependent differences in demographics, risk factors, co-morbidity, etiology, management, and clinical outcome of acute ischemic stroke. J Neurol 2008;255:1503-1507.
4. Putaala J, Curtze S, Hiltunen S, Tolppanen H, Kaste M, Tatlisumak T. Causes of death and predictors of 5-year mortality in young adults after first-ever ischemic stroke: The Helsinki young stroke registry. Stroke 2009;40:2698-2703.
5. The NINDS-tPA Stroke Study Group. Generalized efficacy of tPA for acute stroke: Subgroup analysis of the NINDS tPA stroke trial. Stroke 1997;28:2119-2125.
6. Putaala J, Metso TM, Metso AJ, et al. Thrombolysis in young adults with ischemic stroke. Stroke 2009;40:2085-2091.
7. Poppe AY, Buchan AM, Hill MD. Intravenous thrombolysis for acute ischaemic stroke in young adult patients. Can J Neurol Sci 2009;36:161-167.
8. Wahlgren N, Ahmed N, Dávalos A, et al, for the SITSMOST investigators. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): An observational study. Lancet 2007;369:275-282. (Pubitemid 46138121)
9. SITS-ISTR. Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register. Available at: Http://www.acutestroke.org. Accessed July 19, 2011.
10. Hacke W, Kaste M, Bluhmki E, et al, for the ECASS Investigators. Thrombolysis with alteplase 3 to 45 hours after acute ischemic stroke. N Engl J Med 2008;359:1317-1329.
11. Wahlgren N, Ahmed N, Dávalos A, et al, for the SITS investigators. Thrombolysis with alteplase 3-45 h after acute ischaemic stroke (SITS-ISTR): An observational study. Lancet 2008;372:1303-1309.
12. Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke: Definitions for use in a multicenter clinical trial: TOAST: Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993;24:35-41. (Pubitemid 23014379)
13. Berger C, Fiorelli M, Steiner T, et al. Hemorrhagic transformation of ischemic brain tissue: Asymptomatic or symptomatic? Stroke 2001;32:1330-1335. (Pubitemid 32530418)
14. The NINDS t-PA Stroke Study Group. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. Stroke 1997;28:2109-2118.
15. Wahlgren N, Ahmed N, Eriksson N, et al, for the SITSMOST investigators. Safe Implementation of Thrombolysis in Stroke-MOnitoring STudy (SITS-MOST): Multivariable analysis of outcome predictors and adjustment of main outcome results to baseline data profile in randomized controlled trials. Stroke 2008;39:3316-3322.
16. Saposnik G, Di Legge S, Webster F, Hachinski V. Predictors of major neurologic improvement after thrombolysis in acute stroke. Neurology 2005;65:1169-1174. (Pubitemid 41508205)
17. Hill MD, Kent DM, Hinchey J, et al. Sex-based differences in the effect of intra-arterial treatment of stroke: Analysis of the PROACT-2 Study. Stroke 2006;37:2322-2325. (Pubitemid 44337177)
18. Schievink WI. Spontaneous dissection of the carotid and vertebral arteries. N Engl J Med 2001;344:898-906. (Pubitemid 32224399)
19. Putaala J, Metso AJ, Metso TM, et al. Analysis of 1008 consecutive young patients aged 15 to 49 with first-ever ischemic stroke: The Helsinki young stroke registry. Stroke 2009;40:1195-1203.
20. Zinkstok SM, Vergouwen MDI, Engelter ST, et al. Safety and functional outcome of thrombolysis in dissectionrelated ischemic stroke: A meta-analysis of individual patient data. Stroke 2011;42:2515-2520.
21. Chernyshev OY, Martin-Schild S, Albright KC, et al. Safety of tPA in stroke mimics and neuroimaging-negative cerebral ischemia. Neurology 2010;74:1340-1345.
22. Saver JL, Barsan WG. Swift or sure? The acceptable rate of neurovascular mimics among IV tPA-treated patients. Neurology 2010;74:1336-1337.